TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Xlife Sciences Ltd. ( (CH:XLS) ) is now available.
Xlife Sciences AG, in collaboration with saniva diagnostics GmbH, has achieved a significant milestone with the development of NeuroMex, the first certified medical device for early Alzheimer’s detection based on motor responsiveness. The device, which has completed clinical trials and received FDA and MDR certifications, offers 83.5% accuracy and opens up substantial market potential for strategic partnerships in healthcare and pharmaceuticals.
More about Xlife Sciences Ltd.
Xlife Sciences is a Swiss company that functions as an incubator and accelerator, focusing on the commercialization of promising research projects in the life sciences sector. The company aims to bridge the gap between research and healthcare markets, selecting projects in technology platforms, biotechnology, medical technology, and artificial intelligence to advance them to the next stage of development.
Average Trading Volume: 1,835
Technical Sentiment Signal: Sell
Current Market Cap: CHF99.78M
Learn more about XLS stock on TipRanks’ Stock Analysis page.